Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL151 for Parkinson’s Disease and Launch of Its Engage Parkinson’s Website

September 4, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search